Viewing StudyNCT00453167



Ignite Creation Date: 2024-05-05 @ 5:27 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00453167
Status: COMPLETED
Last Update Posted: 2010-07-12
First Post: 2007-03-27

Brief Title: Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer
Sponsor: National Cancer Center Korea
Organization: National Cancer Center Korea

Organization Data

Organization: National Cancer Center Korea
Class: OTHER_GOV
Study ID: NCCCTS-05-155
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Cancer Center Korea
Lead Sponsor Class: OTHER_GOV
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Heung Tae Kim
Old Organization: National Cancer Center Korea

Collaborators